A recent study shows that patients with non-small cell lung cancer reviewed by the University of Kentucky Markey Cancer Center’s Molecular Tumor Board experience improved outcomes, even if they reside in rural Appalachian Kentucky.
The Markey STRONG Scholars Program fosters diversity in cancer research. The 10-week program that aims to provide career and professional development for college sophomores, juniors and seniors.
A recent College of Medicine study found young adults from vulnerable communities are more likely to be exposed to tobacco marketing in their daily lives.
A new study from the lab of Markey Cancer Director Mark Evers, M.D., demonstrates the critical role of the hormone neurotensin in cell proliferation and stem cell function in the small intestine.
A recent study demonstrates that a combination of two drugs used together provides better than expected results, providing a promising treatment strategy for patients with recurrent ovarian cancer.
Lt. Gov. Coleman and several of Kentucky’s female legislators joined UK HealthCare to highlight the work of the Markey Cancer Center's Ovarian Cancer Screening Program.
The initiative aims to create a connected, integrated statewide cancer provider network. 40% of all new cancer cases in Kentucky are directly or indirectly cared for by Markey.
The UK Markey Cancer Center has officially launched a unique new clinical trial to test whether Artemisia annua extract can prevent ovarian cancer recurrence.
The curriculum includes information on cancer data and risk factors in the region, follows national and state science and health education standards, and is tailored to cultural aspects of Appalachian Kentucky.
